Search

Author/Creator Owen, C.

1. AB0470 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) - ONE-YEAR FOLLOW-UP STUDY USING MEPOLIZUMAB ANTI-IL5 THERAPY AS A STEROID SPARING THERAPEUTIC APPROACH. (2nd June 2020)

Authors:
Egan, A.; Sivasothy, P.; Gore, R.; Martinez Del-Pero, M.; Owen, C.; Willcocks, L.; Smith, R.; Burns, S.; Jayne, D.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
1533
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Factors affecting the success of artificial pack formation in an endangered, social carnivore: the African wild dog. (24th February 2019)

Authors:
Marneweck, C.; Becker, P. A.; Beverley, G.; Davies‐Mostert, H. T.; du Plessis, C.; Forssman, K.; Graf, J.; Gusset, M.; Hofmeyr, M.; Kelly, C.; Kilian, P. J.; Marchal, A. F. J.; Marneweck, D. G.; Marnewick, K.; Owen, C.; Postiglione, G.; Slotow, R.; Somers, M. J.; Szykman Gunther, M.; van Dyk, G.
Journal:
Animal conservation
Issue:
Volume 22:Number 5(2019)
Page Start:
493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2. (17th June 2021)

Authors:
Coutre, S. E.; Barr, P. M.; Owen, C.; Robak, T.; Tedeschi, A.; Bairey, O.; Burger, J. A.; Hillmen, P.; Devereux, S.; Grosicki, S.; McCarthy, H.; Li, J.; Simpson, D.; Offner, F.; Moreno, C.; Dai, S.; Szoke, A.; Dean, J. P.; Kipps, T. J.; Ghia, P.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. FIVE‐YEAR FOLLOW‐UP OF FIRST‐LINE IBRUTINIB FOR TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA//SMALL LYMPHOCYTIC LYMPHOMA. (12th June 2019)

Authors:
Tedeschi, A.; Burger, J.; Barr, P.M.; Robak, T.; Owen, C.; Ghia, P.; Bairey, O.; Hillmen, P.; Coutre, S.; Devereux, S.; Grosicki, S.; McCarthy, H.; Li, J.; Simpson, D.; Offner, F.; Moreno, C.; Dai, S.; Lal, I.; Dean, J.P.; Kipps, T.J.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
103
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RECEIVING VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY. (12th June 2019)

Authors:
Wu, J.; Bolen, C.; Seymour, J.F.; Hillmen, P.; Eichhorst, B.; Eldering, E.; Kipps, T.J.; Langerak, A.W.; Mellink, C.; van der Kevie‐Kersemaekers, A.F.; Owen, C.; Chyla, B.; Punnoose, E.A.; Wang, J.; Boyer, M.; Humphrey, K.; Jiang, Y.; Kater, A.P.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
106
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗